Trailing-twelve-month (TTM) revenue is $1.09 Million with a year-over-year growth of (78.30%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $149,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13 |
| Q4 FY2025Period ended 2025-12-31 | $439,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-19 |
| Q1 FY2026Period ended 2026-03-31 | $82,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $420,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $1,090,000 |
Current P/S: $46,640,955 market capitalization ÷ $1,090,000 TTM revenue = 42.79x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $420000.00.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:07:59.632Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| ISRAEL | $1M |
| Other | $9,000 |
| UNITED STATES | $2M |
$1.09M
$1.09 Million
(78.30%)
vs. $5.02M a year ago (TTM)
+8.80%
5 Year compound annual growth rate
1 Year
(78.30%)
3 Year
(4.97%)
5 Year
+8.80%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.02M | ($949,000) | (23.94%) |
| 2024 | $3.96M | +$931,000 | +30.70% |
| 2023 | $3.03M | +$2.37M | +356.09% |
| 2022 | $665,000 | +$278,000 | +71.83% |
| 2021 | $387,000 | ($104,000) | (21.18%) |
| 2020 |
TTM Growth
(78.30%)
3-Year CAGR
(4.97%)
5-Year CAGR
+8.80%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:07:59.632Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $491,000 |
| +$182,000 |
| +58.90% |
